Skip to main content
SpringerLink
Log in

A community-based approach to new antibiotic discovery

  • Comment
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Abstract

The Community for Open Antimicrobial Drug Discovery aims to tap into the potential of the millions of compounds distributed around laboratories globally to be a source of new antibiotic leads by offering free screening for antimicrobial properties, with no strings attached.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cooper, M. A. & Shlaes, D. A. Fix the antibiotics pipeline. Nature, 472, 32 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Payne, D. J. et al. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29–40 (2007).

    Article  CAS  Google Scholar 

  3. Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371–387 (2013).

    Article  CAS  PubMed  Google Scholar 

  4. Shushko, I. et al. ToxAlerts: a web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. J. Chem. Inf. 52, 2310–2316 (2012).

    Article  Google Scholar 

  5. O'Shea, R. & Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51, 2871–2878 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Director of the Community for Open Antimicrobial Drug Discovery, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia.,

    Matthew A. Cooper

Authors
  1. Matthew A. Cooper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew A. Cooper.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

Related links

FURTHER INFORMATION

CO-ADD

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooper, M. A community-based approach to new antibiotic discovery. Nat Rev Drug Discov 14, 587–588 (2015). https://doi.org/10.1038/nrd4706

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4706

  • Springer Nature Limited

This article is cited by

Search

Navigation